JUL 22, 2019 5:43 AM PDT

How to Kill Superbugs

WRITTEN BY: Amanda Mikyska

Researchers at The University of Tokyo and Teikyo University Institute of Medical Mycology, have synthesized three synthetic antibiotics effective in killing superbugs, which typically resistance to antibiotic treatment.  The method used to synthesize the new antibiotic candidates, called "one bead one compound," comes from biological research in creating many unique peptides.  By adopting this approach, the researchers were able to mimic a natural antibiotic of superbugs with thousands of synthetic molecules and decrease research time.  

Organisms like methicillin-resistant Staphylococcus aureus (MRSA) first developed a resistance to the antibiotic vancomycin, developed in the 1950s.  However, resistance to vancomycin has increased dramatically in recent years, by MRSA and other pathogens.  Lysocin e, a natural antibiotic isolated from soil in southwestern Japan, proved to be ten times more effective at killing drug-resistant bugs.  However, superbugs can easily resist two different antibiotic treatments, so the researchers in Tokyo aimed to synthesize a better version of lysocin e. 

Image: Centers for Disease Control and Prevention

 

Lysocin E is a large ring-shaped molecule with 12 side chains.  The "one bead one compound" method creates variations of the structural components that make up lysocin e, then the original elements by the variants one at a time.  This process resulted in over 2400 versions of a lysocin e analogs, all unique synthesized at the same time.  Candidates that could not kill MRSA at all were eliminated first.  Of the 22 remaining candidates, only half were equal or more effective than lysocin e.  Now, the top three candidates are being investigated for further.  

Antibiotic resistance is a significant public health concern, affecting more than 2 million people in the U.S. every year, according to the Centers for Disease Control and Prevention (CDC).  The "one bead one compound" method of producing drug candidates could dramatically cut research time and result in more powerful antibiotics.

 

Sources:  Nature, Centers for Disease Control and Prevention (CDC), TechnologyNetworks

About the Author
Bachelor's (BA/BS/Other)
Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
OCT 28, 2022
Immunology
A Mysterious Molecule That Enables Viruses to Overcome Immunity
A Mysterious Molecule That Enables Viruses to Overcome Immunity
Viruses can infect many different kinds of cells, and those cells can often react directly to the infection. When bacter ...
NOV 07, 2022
Immunology
A High-Fat Diet May Alter Immunity
A High-Fat Diet May Alter Immunity
The physiological impact of various diets has been hotly debated for years. Scientists have now used a mouse model to sh ...
NOV 11, 2022
Drug Discovery & Development
The development of a thermostable vaccine for tuberculosis
The development of a thermostable vaccine for tuberculosis
Tuberculosis is the deadliest infectious disease worldwide (prior to, and aside from COVID-19 infections). Acc ...
DEC 15, 2022
Immunology
Alzheimer's Disease is Linked to Immune Dysregulation in CSF
Alzheimer's Disease is Linked to Immune Dysregulation in CSF
For many years, scientists have searched for the cause of Alzheimer's disease. While a lot of research attention foc ...
DEC 20, 2022
Cell & Molecular Biology
These Immune Cells Can Shield the Brain & Prevent Cognitive Decline
These Immune Cells Can Shield the Brain & Prevent Cognitive Decline
It was once thought that inflammation and immune responses in the brain were limited; that is was a so-called immune pri ...
JAN 19, 2023
Drug Discovery & Development
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Introducing TruCytes™: The Ready-to-Use Immunophenotyping Control for Cell Therapy, Flow Cytometry and Beyond
Are you a cell biologist, immunologist, or flow cytometrist? If so, you know how challenging it is to find quality contr ...
Loading Comments...